Top 3 Cannabis Stocks: Aurora(ACB), Canopy(CGC), New Age(NBEV), high volatility, different directions


  • ACB's stock price has been dogged by financial issues again.
  • Canopy's shares are well bid after it announced a new cannabis-based drink.
  • New Age Beverages Corp. has been struggling despite expectations for higher volatility. 

Weed stocks have been suffering from a hangover at the beginning of the last week of November. Cannabis shares have been struggling with profit-taking after hopes for legalizing marijuana on the federal level in the US had sent equities higher. 

Another reason for the slump stems from Aurora's financials, which have been weighing on the broader sector

Aurora Cannabis Inc. stock Price

Aurora (ACB) has moved forward with its plans for convertible debt swap after 99% of noteholders opted for the early conversion that was due only in March. The Edmonton-based company sent shivers through investors' spines by allowing bondholders to receive the firm's stock at a discount

Nevertheless, the financial action taken by Aurora is still considerably dilutive, but the Canadian company may have had no choice amid growing economic strains.

Aurora Stock Price November 26 ACB falling again

Canopy Growth Corporation Stock Price

While share prices were generally lower, Canopy Growth Corporation (CGC) has weathered the storm, consolidating the gains. The Smith Falls, Ontario based company has announced that it is expanding from the traditional flower and oil products and into beverages. 

Health Canada has granted a license for a new drinks facility at Canopy's headquarters. Constellation Brands, which makes Corona beer and holds a stake in CGC, has provided technical support. 

Canopy Stock Price November 26 CGC

New Age Beverages Corporation Stock Price

Aurora has been dragging down prices of most of the sector, including a company based in Aurora, Colorado. New Age Beverages Corp (NBEV) has been experiencing a slow grind to the downside since the middle of the year when the NASDAQ-traded share kicked off its painful losing streak.

It is trading at the $2 handle, down to levels last seen in September 2018, before it surged all the way to $7.79. Similar to Canopy (CGC), the firm makes cannabis-infused beverages, a growing sector. However, recent financials have failed to impress.

The downfall in earnings and the miss in revenues have been weighing on the stock in recent days. However, gauges of implied volatility and options markets reflect a potential for substantial movements.

NBEV bulls may be hoping that this new volatility may provide the much-needed upswing.

NBEV Stock Price November 26 New Beverages Corp

New Age Beverages Corp long-term chart

Investing in Cannabis Stocks

The US black market continues to dog the profitability of legitimate sales. Some industry experts fear a cycle of defaults for legal cannabis due to fierce competition in the illegal market. 

While the number of states that are enabling pot sales and consumption has been on the rise, marijuana remains outside the law for many Americans. That keeps off-the-radar growers and consumers in business, creating impediments for the adoption.

The US House of Representatives took a significant step forward by promoting the legalization on the federal level. Still, the Senate is set to slow-walk the process in the best-case scenario. Mitch McConnell, the Senate majority leader, is a life-long opponent of any form of decriminalizing any sort of drug. 

Canadian cannabis firm has been facing hurdles also in its domestic market – which remains limited in comparison to the US – amid a slow rollout.

Nevertheless, many investors remain bullish about the sector chances to reach higher ground as companies mature, Canada becomes comfortable with its new status, and the US advances in its long path to full legalization. New Zealand is set to allow pot sales in 2020, also expanding the market. 

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.

Recommended content


Recommended content

Editors’ Picks

EUR/USD holds gains above 1.0700, as key US data loom

EUR/USD holds gains above 1.0700, as key US data loom

EUR/USD holds gains above 1.0700 in the European session on Thursday. Renewed US Dollar weakness offsets the risk-off market environment, supporting the pair ahead of the key US GDP and PCE inflation data. 

EUR/USD News

GBP/USD extends recovery above 1.2500, awaits US GDP data

GBP/USD extends recovery above 1.2500, awaits US GDP data

GBP/USD is catching a fresh bid wave, rising above 1.2500 in European trading on Thursday. The US Dollar resumes its corrective downside, as traders resort to repositioning ahead of the high-impact US advance GDP data for the first quarter. 

GBP/USD News

Gold price edges higher amid weaker USD and softer risk tone, focus remains on US GDP

Gold price edges higher amid weaker USD and softer risk tone, focus remains on US GDP

Gold price (XAU/USD) attracts some dip-buying in the vicinity of the $2,300 mark on Thursday and for now, seems to have snapped a three-day losing streak, though the upside potential seems limited. 

Gold News

XRP extends its decline, crypto experts comment on Ripple stablecoin and benefits for XRP Ledger

XRP extends its decline, crypto experts comment on Ripple stablecoin and benefits for XRP Ledger

Ripple extends decline to $0.52 on Thursday, wipes out weekly gains. Crypto expert asks Ripple CTO how the stablecoin will benefit the XRP Ledger and native token XRP. 

Read more

US Q1 GDP Preview: Economic growth set to remain firm in, albeit easing from Q4

US Q1 GDP Preview: Economic growth set to remain firm in, albeit easing from Q4

The United States Gross Domestic Product (GDP) is seen expanding at an annualized rate of 2.5% in Q1. The current resilience of the US economy bolsters the case for a soft landing. 

Read more

Forex MAJORS

Cryptocurrencies

Signatures